Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

MuMac eyes first round

The Manchester spinout is seeking capital to launch its first product, a test that can detect the early-stage onset of an eye disease called age-related macular degeneration.


Jul 5, 2017

Plymouth screens Molendotech

Frontier IP has received a 20% stake in Molendotech, a new spinout of Plymouth University that has developed a way to test the purity of water.

Jul 5, 2017

Rebel Venture Fund responds to Echo

The student-led university venturing fund from University of Nevada, Las Vegas has committed capital to Echo Payment Systems.

Jul 5, 2017

Germany awards funding to 48 institutions

The Federal Ministry of Education and Research has allocated capital to institutions such as University of Potsdam to bolster technology transfer activities.

Jul 5, 2017

UC Riverside launches $10m Highlander fund

The fund, first announced in October 2016, has been launched with $10m in capital to invest in spinouts and startups that emerge from the university or surrounding region.

Jul 4, 2017

Ryboquin develops $2.3m round

The company has licensed the platform of University College London spinout Nanogenics to develop a cancer treatment.

Jul 4, 2017

Editorial: Brazil breezes through macro headwinds

Over the past few weeks and months, the country has seen positive headlines for large deals, venture fundraising and corporate innovation initiatives.

Jul 3, 2017

Zipkin flies to Parker Institute

Takeda Ventures senior investment director Ilan Zipkin has become the second high-profile departure from the unit in four months to join the Parker Institute for Cancer Immunotherapy.

Jul 3, 2017

LogicBio makes sense of $45m series B

LogicBio is developing treatments for orphan paediatric diseases, based on research conducted at Tel Aviv University, Stanford University and Children's Medical Research Institute.

Jun 30, 2017
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here